title: Increased adhesion of fibroblasts from patients with scleroderma to extracellular matrix components: in vitro modulation by IFN-gamma but not by TGF-beta.
abstract: A characteristic feature of systemic scleroderma is fibrosis of the skin and eventually of internal organs resulting from an overproduction of collagen and other connective tissue components by the resident fibroblasts. The balance between the cells and the amount of the surrounding extracellular matrix is then altered. Because cellular metabolism depends to a large extent on cellular contacts and communications with connective tissue molecules, we have therefore investigated the interactions with extracellular matrix components of fibroblasts obtained from skin of patients affected with scleroderma. In comparison to fibroblasts from healthy skin, all fibroblasts from scleroderma patients had an increased adhesion capacity to collagens I, IV, VI, fibronectin, and laminin. In addition, whereas adhesion of control fibroblasts was stimulated by a pre-treatment with transforming growth factor-beta, adhesion patterns of scleroderma fibroblasts remained unchanged. However, pre-incubation of the cells with interferon-gamma decreased the adhesion of both scleroderma and control fibroblasts.
authors.affiliation: Department of Dermatology, University of Cologne, Federal Republic of Germany.
authors.forename: S
authors.initials: S
authors.lastname: Majewski
authors.forename: N
authors.initials: N
authors.lastname: Hunzelmann
authors.forename: C G
authors.initials: CG
authors.lastname: Schirren
authors.forename: C
authors.initials: C
authors.lastname: Mauch
authors.forename: M
authors.initials: M
authors.lastname: Aumailley
authors.forename: T
authors.initials: T
authors.lastname: Krieg
mesh_terms: D002448:Cell Adhesion / Q000187:drug effects; D003094:Collagen / Q000378:metabolism*; D003238:Connective Tissue / Q000473:pathology; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology; D005353:Fibronectins / Q000378:metabolism*; D005355:Fibrosis; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000378:metabolism / Q000473:pathology*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D005353:Fibronectins; D016212:Transforming Growth Factor beta; D007371:Interferon-gamma; D003094:Collagen